Source and scope
This summary is bounded to the recommendations, population and decisions covered by Canadian Contraception Consensus, Chapter 7: Intrauterine Contraception. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:SOGC intrauterine contraception
Source-attributed clinical priorities
- Offer intrauterine and implant methods without restricting them by age or parity when medically eligible.
- Use shared decisions on effectiveness, bleeding pattern, pain management, duration, reversibility and noncontraceptive benefits.
- Exclude pregnancy and active relevant infection as indicated and provide complication and removal-access advice.
- Confirm that removal will be available whenever the patient requests it before insertion.
sources for this section:SOGC intrauterine contraception
Practical assessment and management workflow
1
Clarify pregnancy risk, bleeding goals, uterine history, infection risk, medicines and preferred duration.
2
Discuss implant and intrauterine options, procedural pain, expected bleeding and noncontraceptive effects.
3
Use a trained insertion technique after relevant examination and testing.
4
Confirm placement where required and provide written advice on complications, bleeding and removal.
sources for this section:SOGC intrauterine contraception
Safety, red flags and urgent escalation
- Pregnancy, active pelvic infection or unexplained concerning bleeding needs assessment before an intrauterine method.
- Severe pain, fever, heavy bleeding or a missing device with pregnancy symptoms requires urgent review.
- Check enzyme-inducing interactions for the implant and do not assume all long-acting methods are affected equally.
sources for this section:SOGC intrauterine contraception
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:SOGC intrauterine contraception
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:SOGC intrauterine contraception
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Society of Obstetricians and Gynaecologists of CanadaCanadian Contraception Consensus, Chapter 7: Intrauterine Contraceptionaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.